Top-Rated Biotech Surges On A Bullish Win In Cancer - Investor's Business Daily
Last Updated: 25.06.2025 05:18
Exelixis (EXEL) stock surged Monday after the biotech company said its next-generation cancer drug showed promise in a study of patients with hard-to-treat colon cancer.
The company tested a combina… [+3212 chars]